Today, Explained Booster shots
Aug 24, 2021
In this engaging discussion, science writer Umair Irfan explains the FDA's recent approvals for COVID-19 vaccines and the push for booster shots. Sarah Zhang from The Atlantic shares her insights on living with the virus long-term, emphasizing that while COVID-19 may stick around, it might not be as daunting in the future. They humorously navigate vaccine marketing, ethical dilemmas of booster distribution, and our adaptation to an endemic reality. Tune in for an enlightening take on our ongoing relationship with this virus!
AI Snips
Chapters
Transcript
Episode notes
Rapid FDA Approval
- The FDA fully approved the Pfizer vaccine in record time, not by cutting corners, but due to the pandemic's urgency.
- They devoted extra resources, overlapped trial phases, and quickly recruited a huge number of people.
Impact of Full Approval
- Full FDA approval allows for mandates in workplaces, public institutions, and schools.
- It empowers doctors to prescribe the vaccine off-label to individuals outside the authorized age range, such as high-risk children.
Vaccine Marketing
- Full FDA approval enables Pfizer/BioNTech to market their vaccine, Comirnaty, even if it seems unnecessary during a pandemic.
- This contrasts with Moderna's Spikevax, prompting humorous speculation about marketing campaigns.